MANE
Veradermics, Inc
Key Financials
EPS (Diluted)
$-111.91
↓ 202.1%
Operating Income
$-72347000
↓ 170.2%
Net Income
$-69995000
↓ 164.3%
Total Assets
$152.6M
↑ 174.8%
Total Liabilities
$9.2M
↑ 94.1%
Cash & Equivalents
$21.8M
↓ 59.0%
Operating Cash Flow
$-71602000.00
↓ 202.3%
Shareholders' Equity
$-121014000.00
↓ 149.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| D | 5/15/2026 | View on SEC |
| 10-Q | 5/12/2026 | View on SEC |
| 8-K | 5/12/2026 | View on SEC |
| SCHEDULE 13G | 5/7/2026 | View on SEC |
| SCHEDULE 13D/A | 5/5/2026 | View on SEC |
| 4 | 5/5/2026 | View on SEC |
| SCHEDULE 13D/A | 5/5/2026 | View on SEC |
| SCHEDULE 13D | 5/5/2026 | View on SEC |
| 3 | 5/5/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | MANE |
| Company Name | Veradermics, Inc |
| CIK | 1827635 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | NYSE |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 228.372.3376 |